How High Performing Health Plans Excel at Colorectal Cancer Screening
Four Reasons Every Medicare Advantage Plan Should Invest in At-home Screening for Colorectal Cancer
Improving HEDIS® and STARS scores presents many challenges, limited resources, and few true solutions that are effective at scale. Nowhere is this more evident than in the Medicare Advantage market, where the “race to the top” has resulted in unprecedented pressure to improve the delivery of preventive services like colorectal cancer screening. Thanks to the availability of effective at-home screening tests, colorectal cancer screening is one quality measure that every Medicare Advantage plan can excel at.
This eBook outlines four reasons every Medicare Advantage plan should invest in at-home screening for colorectal cancer (CRC).
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). NCQA does not endorse any BioIQ services or products.